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Stat3Stat3 (Signal Transducer and Activator of Transcription-3) is activated by a number of receptor and nonreceptor
tyrosine kinases. We recently demonstrated that engagement of E-cadherin, a calcium-dependent, cell to cell
adhesion molecule which is often required for cells to remain tightly associated within the epithelium, also acti-
vates Stat3.We now examined the effect of two other classical cadherins, cadherin-11 and N-cadherin, whose ex-
pression often correlateswith the epithelial tomesenchymal transition occurring inmetastasis of carcinoma cells,
upon Stat3 phosphorylation and activity. Our results indicate that engagement of these two cadherins also, can
trigger a dramatic surge in Stat3 activity. This activation occurs throughupregulation ofmembers of the IL6 family
of cytokines, and it is necessary for cell survival, proliferation and migration. Interestingly, our results also
demonstrate for the ﬁrst time that, in sharp contrast to Stat3, the activity of Erk (Extracellular Signal Reg-
ulated kinase) was unaffected by cadherin-11 engagement. Further examination indicated that, although
IL6 was able to activate Erk in sparsely growing cells, IL6 could not induce an increase in Erk activity levels
in densely growing cultures. Most importantly, cadherin-11 knock-down did allow Erk activation by IL6 at
high densities, indicating that it is indeed cadherin engagement that prevents Erk activation by IL6. The fact
that the three classical cadherins tested so far, E-cadherin, N-cadherin and cadherin11, which are present in
essentially all tissues, actually activate Stat3 regardless of their role in metastasis, argues for Stat3 as a central
survival, rather than invasion factor.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Cadherins are a superfamily of transmembrane glycoproteins that
are involved in the formation of cell to cell junctions in a variety of tis-
sues [1,2]. Cadherins control the organization, speciﬁcity and dynamics
of cell–cell adhesion,which is crucial for the development,maintenance
and homeostasis of tissue architecture and function [3,4]. Classical
cadherins consist of an extracellular domain, a single-pass transmem-
brane domain and a highly conserved intracellular domain,which inter-
acts with the cytoskeleton via cytoplasmic proteins, such as catenins.
The ectodomain consists of ﬁve modules (EC1 to EC5) of ~100 amino
acids each with internal sequence homology [5,6]. Upon calcium bind-
ing, the EC domains change conformation, favoring the formation ofgy and Immunology, Queen's
ada K7L3N6. Tel.: +1 613 533
ular Medicine, Centre for Inno-
itute, 501 Smyth Road, Ottawa,
rights reserved.cadherin-mediated, adhesive structures between adjacent cells [7,8].
The extracellular segments expressed on the surface of opposing cells
interact in a homophilic manner to create highly regulated patterns of
attachment, stabilized by cytoskeletal elements inside the cells [9]. Clas-
sical cadherins are subdivided into type I (E, N, P and R) and type II (VE,
6–12, 15, 18, 19) based on the structure of their extracellular domains
[10]. While both types induce cell to cell adhesion and interact with
catenins, cells expressing cadherins 7–11 aggregate less efﬁciently than
cells expressing E- or N-cadherin [11]. These differences could be due to
differences in the intrinsic structure of the extracellular EC1 domain
that confers adhesive speciﬁcity [12–14].
The best characterized classical type I cadherin is the epithelial
(E)-cadherin, which is involved in the formation and maintenance of
epithelial structures and is abundant in cultured cells of epithelial origin
[4,15]. Early results showed that continuedplasmamembrane expression
of E-cadherin is required for cells to remain tightly associated within the
epithelium, so that loss of E-cadherin function, including mislocalization
to the cytoplasm from the membrane, is associated with metastasis of
invasive breast cancer [16–18]. Other cadherins however, such as
N-cadherin and cadherin-11, recently deﬁned as “mesenchymal” [19],
have been positively implicated in cancer as putative proto-oncogenic
proteins and are often upregulated in tumor tissues. Indeed, N-cadherin
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a highly invasive phenotype and motility in mammary cell lines [20–22].
In addition, normal squamous epithelial cell lines acquired migratory
properties upon transfection with N-cadherin [23]. Interestingly, in cer-
tain tumour lines, such as MCF7 breast cancer cells which express
E-cadherin and are not motile, transfected N-cadherin conferred a mi-
gratory phenotype, despite the presence of the endogenous E-cadherin
[21,24].
Cadherin-11 (classical type II) was originally identiﬁed inmouse oste-
oblasts [25], but it was later found to be constitutively expressed in a
variety of normal tissues ofmesodermal origin, such as areas of the kidney
and brain [26], as well as in cultured ﬁbroblasts [27]. Cadherin-11 was
also shown to be elevated in a number of cancers where it correlates
with a poor prognosis, and is linked to breast cancer metastasis [28,29].
Although it is not expressed in normal human prostate epithelial cells, it
is present in prostate cancer, with its expression increasing from primary
tometastatic disease to the bone, a tissuewhere cadherin-11 is abundant-
ly expressed, further suggesting that cadherin-11 could be associated
with metastasis [30,31]. It follows that examination of the mechanism
of action of the different types of cadherins is of paramount importance
in the study of cell to cell adhesion as well as metastasis.
The Signal Transducers and Activators of Transcription (STATs, Stat1
to Stat6) are key mediators of cytokine responses in the mammalian
cell. Stat3 is activated by receptor tyrosine kinases, such as the epider-
mal growth factor receptor (EGFR) or platelet-derived growth factor
receptor (PDGFR), as well as the non-receptor tyrosine kinase Src. In
quiescent cells Stat3 is found in the cytoplasm. Following receptor stim-
ulation, Stat3 is phosphorylated at the critical tyr-705 by the activated
receptor or the associated Jak or Src kinases. This activates Stat3 by
stabilizing the association of two monomers through reciprocal Src
homology 2 (SH2)-pTyr interactions. The Stat3 dimer then migrates to
the nucleus where it activates the transcription of speciﬁc genes in-
volved in cell division and survival [32]. Stat3 activity is required for
transformation by a number of oncogenes and is found to be hyperac-
tive in a number of cancers [33]. The fact that a constitutively active
form of Stat3 alone is sufﬁcient to induce neoplastic transformation
points to an etiological role for Stat3 in neoplasia.
We and others recently demonstrated that cell–cell adhesion causes
a dramatic increase in the activity of Stat3 in breast carcinoma aswell as
normal epithelial cells and ﬁbroblasts ([34,35] reviewed in [36]). We
further demonstrated that, in vitro and in vivo, E-cadherin engagement
in mouse breast epithelial cells directly induces a dramatic increase in
Rac and Stat3 activity, and this constitutes a potent survival signal [37].
This prompted us to examine the effect of the “mesenchymal” cadherins,
N-cadherin and cadherin-11, which belong to the type I and type II clas-
sical cadherins, respectively, andwhose expression often correlateswith
metastasis, upon Stat3 phosphorylation and activity. Our results indicate
that engagement of these cadherins can also trigger a dramatic surge in
Stat3 activity. This activation occurs through upregulation of members
of the IL6 family of cytokines, which is necessary for cell survival, prolif-
eration and migration. The fact that the “mesenchymal” cadherin-11
and N-cadherin actually activate Stat3, although, contrary to the epithe-
lial E-cadherin, they generally promotemetastasis, may point to Stat3 as
a central survival, rather than metastasis factor.
Taken together, these data suggest that interferencewith cadherin-11
orN-cadherin function could induce apoptosis through Stat3 inhibition in
metastatic tumor cells speciﬁcally, a fact which could have important
therapeutic implications.2. Materials and methods
2.1. Cell lines, culture techniques and gene expression
Normal mouse Balb/c3T3 and Balb/c3T3 transformed by v-Src and
mouse 10T½ﬁbroblastswere grown inDulbecco'smodiﬁcation of Eagle'smedium (DMEM), supplementedwith 10% fetal calf serum, as previously
described [34].
The plasmid constructs coding for the ﬁrst two extracellular domains
of E-cadherin (E/EC12) or cadherin-11 (11/EC12), fusedwith aC-terminal
hexahistidine tag were previously described [12,13]. Cadherin fragment
expression was induced by the addition of IPTG for 2 h. The fragments
were puriﬁed and attached as before [37]. Cell pellets were resuspended
in lysis buffer: 4 M urea, 50 mM Na2HPO4 pH 7.8, 20 mM Imidazole
and 20 mM β-mercaptoethanol if needed. Puriﬁcation was carried out
by Ni-afﬁnity chromatography as previously described [12,13]. Puriﬁed
preparations of each cadherin fragment yielded only one band upon anal-
ysis by 15% SDS-PAGE and Coomassie blue staining. Puriﬁed fragments
were attached to plastic petris as follows: Petris were treated with poly-
DL-lysine (Sigma # P4158, 0.1 mg/ml in H2O, for 1 h at room tempera-
ture), followed by Calcium-free phosphate buffered saline (PBS) washing
and glutaraldehyde treatment (SigmaG-5882, 2.5% in PBS, for 1 h at room
temperature). The cadherin fragmentswere subsequently added at a con-
centration of 0.5–1000 μg/ml for 2 h, followed by glycine treatment
(0.2 M in PBS, overnight). The petris were washedwith PBS and incubat-
ed with DMEM for 1 h, prior to the addition of cells in complete medium
containing serum. Growth of cells on the E/EC12 or 11/EC12 fragments
did not cause any detectable change in morphology.
Cell conﬂuence was estimated visually and quantitated by imaging
analysis of live cells under phase contrast using a Leitz Diaplan micro-
scope and the MCID-elite software (Imaging Research, St. Catharine's
Ont.). In addition, the amount of total protein extracted was also used
as a surrogate measure of total cell density. To reduce the variability
that might be caused by nutrient depletion in post-conﬂuent cultures,
the medium was changed every 24 h.
Rac1 and Cdc42 knockdown were performed using shRNA's
expressed through retroviral vectors as described [37].
Fixed cells were assayed for apoptosis using a TUNEL assay (Roche)
as previously described [34].
Anti-ubiquitin immunoprecipitations were conducted using the FK2
antibody (Biomol) andGammaBind Plus Sepharose beads (GEHealthcare
Life Sciences).
For NFκB inhibition, cells were treated with 20 μm IKK-inhibitorIII
(BMS-345541) or 20 μg/ml CAPE (EMD Biosciences). For Jak inhibition,
cells were treated with the Jak inhibitor I (EMD Biosciences), for 8 h at
20 μM. For inhibition of the proteasome, cells were treatedwithMG132
for 8 h at 10 μM.Cell viabilitywas ensured by trypan blue exclusion and
by replating the cells in medium lacking the inhibitor.
2.2. Wound healing assay
Cells were plated in 3 cm tissue culture petri dishes in DMEM/10%
fetal calf serum, for next day conﬂuence. A wound was made on the
conﬂuent monolayer with a plastic pipette tip and cell migration was
monitored over a 24-hr period using an Olympus IX70 inverted micro-
scope. Phase contrast images of the same marked ﬁelds were captured
at various times. The area of wound closure, relative to t = 0 h was
measured in two independent experiments, four wound sites per cell
line, using ImageJ software. Relative cell motility was calculated as the
difference between the wound area at t = 0 h and the indicated time
point. Mean values ± SD per group were calculated, and statistical sig-
niﬁcance among groups assessed using one-way analysis of variance
[38].
2.3. Western blotting
Cell extracts were prepared as described [34]. Following a careful pro-
tein determination (BCA-1 Protein assay kit, Sigma), 30 μg of clariﬁed cell
extract were loaded. Blots were probed with antibodies against phos-
phorylated Stat3 tyr-705 and total Stat3 protein (Cell Signalling), Rac1
or Cdc42 (BD Transduction Labs), the dually phosphorylated form
of Erk1/2 (Biosource), or Hsp90 (Stressgen) or α-tubulin as loading
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antibodies (Biosource) or horseradish peroxidase-conjugated goat sec-
ondary antibodies (Jackson Labs and Pierce). The bands were visualized
using enhanced chemiluminescence (ECL), according to the manufac-
turer's instructions (PerkinElmer Life Sciences, Cat.# NEL602) or using
SuperSignal West Femto Maximum Sensitivity Substrate (Pierce, Rock-
ford, Ill.). Quantitation was achieved by ﬂuorimager analysis using the
FluorChem program (AlphaInnotech Corp). Luciferase assays for Stat3
transcriptional activity were performed as previously described [34,35].
2.4. Immunohistochemistry
Cell pellets were embedded in parafﬁn and sectioned. Sections were
subsequently deparafﬁnized and hydrated in a gradient alcohol series
from 100% to 70%, then placed under running water for 5 min.
Heat-mediated antigen retrieval was performed by heating the slides to
92 °C in low pH buffer for 20 min (Target Retrieval Solution, low pH,
Dako), then washed in wash buffer (Dako). Cadherin-11 was detected
using rabbit anti-cadherin-11 puriﬁed IgG and the Dako EnVision
FLEX + Rabbit (linker) kit followed by EnVision + System-HRP labelled
polymer (Peroxidase labelled polymer conjugated to goat anti-rabbit IgG,
Dako). The color reaction was developed by DAB + chromogen in sub-
strate buffer (Dako), resulting in a brown reaction product. Sections
were counterstainedwithMayer's hematoxylin, dehydrated in a gradient
series of alcohol, cleared in xylene and mounted.
2.5. Rac1 activation assays
They were performedwith the Rac1/Cdc42 activation assay kit (Cyto-
skeleton, #BK035), using beads coated with glutathione-S-transferase
(GST) fused to the binding domain of the p21 activated kinase 1
(PAK-PBD) in pulldown assays. Adding twice the amount of PBD-coated
beads did not increase the signal, indicating that the amount of binding
partner used in the detection was not limiting.
2.6. RT-PCR assays
RT-PCRwas performed using Superscript III First-Strand Synthesis kit
(Invitrogen) in an Eppendorf Personal Mastercycler. All quantitative
RT-PCR reactions were performed with 1x SYBR Green Master Mix
(BioRad) using the Corbett Rotor-Gene 6000. Serial ten-fold dilutions of
18S RNA were used as a reference for the standard curve calculation.
The primer pairs for Rac1 ampliﬁcation were: forward primer 5′GGAC
ACAGCTGGACAAGAAGA and the reverse primer 5′GGACAGAGAACCG
CTCGGATA to generate a 368 bp fragment. For Cdc42 the primer pairs
were: forward primer 5′CGACCGCTAAGTTATCCACAG and the reverse
primer 5′GCAGCTAGGATAGCCTCATCA to generate a 325 bp fragment.
18S RNA (153 bp) was used as a control.
For quantitative RT-PCR, the delta ct (Δct) value was calculated
from the given ct value by the formula: Δct = (ctsample − ctcontrol).
The fold change was calculated as the value of 1.94−Δct, 1.94 being
the average PCR efﬁciency. For the qRT-PCR cytokine array, we used
the PAMM-021A kit (SA Biosciences) with an RT-PCR for IL6 run in
parallel, according to the manufacturer's protocol.
3. Results
3.1. Engagement of “mesenchymal” cadherins increases Stat3 activity
Themouse ﬁbroblast line Balb/c3T3was previously shown to express
cadherin-11 [27]. In fact, as shown in Fig. 1A, these cells possess signiﬁ-
cant amounts of cadherin-11 mRNA (upper panel) and protein (lower
panel), while E-cadherin mRNA is undetectable.
To investigate the effect of cadherin-11 engagement upon Stat3
activity, the impact of cell density was initially examined. Balb/c3T3
cells were plated in plastic petri dishes, and when ~50% conﬂuent,and over several days thereafter, detergent cell extracts were probed
by Western blotting for the tyrosine-705 phosphorylated form of
Stat3 (Stat3-ptyr705) ([34] (see Materials and methods)). As a loading
control, the same extracts were probed with an antibody against the
abundant heat shock protein, Hsp90 [39]. As shown before for a number
of normal cell lines [34], Stat3-ptyr705 levels were almost undetectable
in sparsely growing, Balb/c3T3 cells (Fig. 1B, lane 1). However, density
caused a dramatic increase, and Stat3-ptyr705 plateaued at 2–3 days
after conﬂuence (lanes 5–6), to levels approximately half the levels
present in cells transformed by the potent Stat3 activator, v-Src (lane
9), and decreased slightly thereafter. Probing for total Stat3 revealed a
modest increasewith cell density (approximately 2.5 fold, Fig. 1B), pos-
sibly due to the fact that the Stat3 promotor itself is one of the Stat3 tar-
gets [40]. This activation was speciﬁc to Stat3, since the levels of Erk1/2
(and Akt 473), a signal transducer often coordinately activated with
Stat3 by a number of growth factors and oncogenes, remained unaffected
by cell density (Fig. 1B). The above results indicate that cell density causes
a speciﬁc increase in Stat3-ptyr705 levels in mouse Balb/c3T3 ﬁbroblasts.
We next examined the effect of density upon Stat3 transcriptional
activity using Balb/c3T3 cells expressing a Luciferase gene construct
under control of a Stat3-speciﬁc promotor (pLucTKS3 plasmid, see
Materials and methods). As shown in Fig. 1C, there was a dramatic in-
crease in Stat3-dependent transcriptional activity. At the same time,
Stat3-independent transcription from the c-fos, SRE promotor element
was not affected by cell density, suggesting that density induces Stat3
activity speciﬁcally. In addition, cell density increased the levels of the
Stat3 transcriptional target, survivin (Fig. 1C, lower panel [41]), in keep-
ing with data from other lines (reviewed in [36]). The above data taken
together indicate that density increases Stat3, tyr705 phosphorylation
and activity in Balb/c3T3 mouse ﬁbroblasts.
To examine whether cadherin-11 was indeed responsible for the
density-mediated increase in Stat3-ptyr705 levels, cadherin-11 was
knocked down through stable sh-RNA expression with a retroviral vec-
tor (seeMaterials andmethods). As shown in Fig. 1D, infectionwith this
vector essentially eliminated cadherin-11 as shown byWestern blotting
(Fig. 1D, panel a) and immunocytochemistry (panel b). Interestingly,
cadherin-11 knockdown resulted in a dramatic reduction in Stat3-
ptyr705 levels (panel c), indicating that this cadherin is indeed required
for the Stat3, tyr705 phosphorylation observed at high densities. Most
importantly, these data also indicate that, at this point, Balb/c3T3 ﬁbro-
blasts do not express signiﬁcant amounts of other Stat3 activators (such
as other cadherins) that might operate at high cell densities.
The type I classical cadherin, N-cadherin, has also been documented
to correlate with metastasis of tumor cells [20], therefore we examined
its effect upon Stat3 activity and survival. To this effect, we made use of
the null, embryonal stem (ES) cells where E-cadherin was genetically
ablated [37]. These cells have very low background levels of Stat3,
which might be due to the Leukemia inhibitory factor (LIF) necessary
for their growth [37]. Indeed, N-cadherin expression in null cells [4]
caused an increase in Stat3-ptyr705, indicating that N-cadherin can
also activate the Stat3 pathway in this cellular setting (Fig. S1, B, supple-
mentary data).
To further conﬁrm the ability of N-cadherin to activate the Stat3 path-
way, we transfected a construct of N-cadherin-GFP in HEK-293 cells
which express low levels of N-cadherin (Fig. S1 C, lane 3). As shown in
Fig. S1, C (lanes 1 and 2 vs lane 3), N-cadherin expression caused a
dramatic increase in Stat3-ptyr705 levels, further conﬁrming that
N-cadherin also activates Stat3 following transient expression. Taken
together, the above data indicate that cadherin-11 and N-cadherin,
which, contrary to E-cadherin correlate with metastasis of epithelial
cells, also activate the Stat3 pathway.
3.2. Cadherin11 engagement is sufﬁcient for direct Stat3 activation
We next investigated whether the Stat3 activation observed at high
densities is a direct consequence of the engagement of cadherin-11, or
Fig. 1. Cell density triggers Stat3 phosphorylation in Balb/c3T3 cells. A: Balb/c3T3 cells express cadherin-11 but not E-cadherin. Upper panel: RNA extracts from Balb/c3T3, mouse
ﬁbroblasts or the HC11, mouse breast epithelial line were probed by RT-PCR for E-cadherin (lanes 1 and 2) or cadherin-11 (lanes 3 and 4), using 18S RNA as an internal control
(lanes 6 and 7) (see Materials and methods). Numbers at the left refer to the oligonucleotide marker lane (M). Lower panel: Detergent extracts from Balb/c3T3 (lane 2), control
Balb/c3T3 cells infected with a pBabe-puro vector and selected for puromycin resistance (lane 1) or mouse breast epithelial HC11 cells were probed for cadherin-11, with
GAPDH as a loading control. B: Cell density upregulates Stat3-ptyr705 levels in Balb/c3T3 cells. Lysates from Balb/c3T3 ﬁbroblasts grown to increasing densities were resolved
by gel electrophoresis and probed for Stat3-ptyr705, total Stat3, phospho-Erk1/2, Akt-pser473 or Hsp90 as a loading control, as indicated (see Materials and methods). Numbers
at the left refer to molecular weight markers. vSrc: vSrc-transformed, Balb/c3T3 ﬁbroblasts. C: Cell density upregulates Stat3 transcriptional activity in Balb/c3T3 cells. Upper
panel: Balb/c3T3 cells were transfected with the Stat3-dependent pLucTKS3 reporter driving a ﬁreﬂy luciferase gene under control of the C-reactive gene promoter element, and
the Stat3-independent pRLSRE reporter driving a Renilla luciferase gene under control of the c-fos SRE promotor, respectively. Cells were grown to the indicated densities with
daily media changes and ﬁreﬂy (■) or Renilla (□) luciferase activities determined in cytosolic extracts (see Materials and methods). Values shown represent luciferase units
expressed as a percentage of the highest value obtained, means ± SEM of at least 3 experiments, each performed in triplicate. Lower panel: Detergent cell extracts of Balb/c3T3
cells were probed for the Stat3 target, survivin, or Hsp90 as a loading standard, as indicated. Numbers at the left refer to Molecular Weight markers. D: Cadherin-11 knockdown
causes a dramatic reduction in Stat3-ptyr705 in Balb/c3T3 cells. a. Extracts from 2 independent clones of sh-Cad11 expressing, Balb/c3T3 clones (lanes 1 and 2), Balb/c3T3 cells
infected with an empty vector and selected for puromycin resistance (lane 3) or the parental Balb/c3T3 cells (lane 4), all grown to high densities, were probed for cadherin-11
or GAPDH as a loading control. Note the dramatic reduction in cadherin-11 levels in sh-Cad11-expressing clones, compared to Balb/c3T3. b. Pellets of Balb/c3T3 (right panel) or
Balb-shCad11 (left panel) cells were sectioned and stained for cadherin-11 (see Materials and methods). Note the absence of staining in Balb-shCad11 cells. c. Detergent extracts
from control Balb/c3T3 (lanes 1–6) or shCad11-expressing, Balb-shCad11 cells (lanes 7–12) were probed for Stat3-ptyr705 or GAPDH as a loading control. Note the dramatic
reduction in Stat3-ptyr705 levels in shCad11-expressing clones.
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cell surfaces into proximity, to initiate signals which are not immedi-
ate effects of cadherin ligation. To deﬁnitively answer this question,
we made use of a recombinant cadherin-11 fragment, encompassing
the two distal, extracellular domains of cadherin-11 (11/EC12) to
functionalize petri dishes by covalent immobilization. This fragment
has been shown to retain biological activity when attached onto solid
surfaces [12]. Plastic, 3 cm petri dishes were coated with increasing
amounts of puriﬁed 11/EC12 fragment, from 0 to 1000 μg/ml, and
30,000 Balb/c3T3 cells were plated on these surfaces (see Materials and
methods). Detergent cell extracts were prepared 48 h later, when cells
were 30% conﬂuent, and probed for Stat3-ptyr705 as above. No differ-
ence in cell morphology was noted when the cells were plated on these
coated surfaces, compared to plastic (not shown). As shown in Fig. 2,
there was a dramatic and graded increase in Stat3-ptyr705 levels, in
proportion to the amounts of 11/EC12 used to decorate these surfaces
(lanes 2–5), while there was no increase in Stat3-ptyr705 when Balb/
c3T3 cells were plated on petri dishes coated with the corresponding
fragment derived from E-cadherin (E/EC12), as a negative control
(Fig. 2, lane 1). As a further control, normal mouse breast epithelial
HC11 cells which are naturally devoid of cadherin-11 (Fig. 1A), were
plated on surfaces coated with 11/EC12 or on the corresponding,
E-cadherin fragment E/EC12. As expected, there was no increase in
Stat3-ptyr705 when HC11 cells were grown on surfaces coated with
11/EC12 (Fig. 2, lanes 7 and8),while therewas an increase upon growth
of HC11 cells on surfaces coated with the homologous E/EC12 fragment
(lane 9), which argues for a speciﬁcity of cadherin interactions. The in-
crease in Stat3-ptyr705 required at least 20 h andwasmost pronounced
when cells were at a conﬂuence of 35% or less, while at higher densities
the Stat3 activation caused by direct cell–cell contact obscured the Stat3
activation brought about by cadherin ligation to the 11/EC12 fragment
coating the plate. Similar results were obtained with the 10T½, mouse
ﬁbroblasts, which also express cadherin 11 (not shown). The increaseFig. 2. Cadherin-11 engagement is sufﬁcient to activate Stat3 in Balb/c3T3 ﬁbroblasts.
Balb/c3T3 cells were grown in plastic 3 cm dishes, coated with increasing amounts of
the cadherin-11 fragment, 11/EC12 (lanes 2–5). 48 h later, cell lysates were probed for
Stat3-ptyr705, phospho-Erk1/2 or Hsp90 as a loading standard, as indicated. As controls,
Balb/c3T3 cells, which are devoid of E-cadherin (Fig. 1A), were grown on a surface coated
with the corresponding E-cadherin fragment (E/EC12, lane 1) and HC11 cells which are
devoid of cadherin-11 were grown on surfaces coated by 11/EC12 (lane 8), or E/EC12 as
a positive control (lane 9). Numbers under the lanes refer to band intensities obtained
by densitometric scanning, with Balb/c3T3 cells grown to one day after conﬂuence (lane
6), or HC11 cells grown on surfaces coated with 1000 μg/ml E/EC12 fragment (lane 9)
taken as 100% for lanes 1–6 and 7–9, respectively (see Materials and methods).was speciﬁc to Stat3, since no increase in Erk1/2 was ever noted under
these conditions (Fig. 2, middle panel). The dramatic and speciﬁc in-
crease in Stat3-ptyr705 upon direct cadherin-11 engagement in mouse
ﬁbroblasts, which was proportional to the density of 11/EC12 present
on the culture surface, indicates that cadherin-11 engagement is sufﬁ-
cient to activate Stat3.
3.3. Cadherin-11 engagement increases the activity as well as protein
levels of the Rac1/Cdc42 GTPases
Early data demonstrated that cell to cell adhesion activates the Rac1,
Rho familyGTPase (reviewed in [42]). Therefore, to examine thepotential
role of Rac1 in the cadherin-11 dependent, Stat3 activation in our system,
Rac1 activity was examined in Balb/c3T3 cells grown to different densi-
ties. This was performed by assessing the binding between Rac1-GTP
and its effector p21-activated kinase (PAK) in cell extracts using pull-
down assays as before [37] (see Materials and methods). As shown in
Fig. 3A, conﬂuent Balb/c3T3 cultures had substantially higher Rac1-GTP
levels than their counterparts growing at a density of 40% (lane 1 vs 4).
Similar results were obtained with mouse 10T½ ﬁbroblasts which also
express cadherin-11 (not shown). The above results demonstrate that
cell density causes a dramatic increase in the activity of Rac1, in both
types of mouse ﬁbroblasts.
It was previously demonstrated that Rac1 can be subjected to
proteasome-mediated degradation [43]. Therefore, to explore the poten-
tial effect of cadherin-11 engagement upon the levels of total Rac1 pro-
tein, detergent extracts from cells grown to different densities were
blotted and probed for Rac1. As shown in Fig. 3A, there was a sharp in-
crease in total Rac1 protein levels with cell density, which could explain
the increase in active Rac1-GTP at high densities. Similar results were
obtained with 10T½mouse ﬁbroblasts (not shown). These results indi-
cate that, in addition to Rac1 activity, cell–cell adhesion also causes a
dramatic increase in total Rac1 protein levels.
To investigate whether the increase in Rac1 protein levels with
cell density is due to direct cadherin-11 engagement, Balb/c3T3 cells
were plated in 11/EC12-coated dishes as above and Rac1 protein
levels examined. As shown in Fig. 3B, plating on 11/EC12-coated surfaces,
besides leading to an increase in Stat3-ptyr705, also caused a dramatic in-
crease in Rac1 protein levels.
We next examined the effect of cadherin-11 knockdown upon Rac1.
Balb-shCad11 cells were plated to different densities and Rac1 levels
examined and compared to the parental Balb/c3T3 cells by Western
blotting analysis. As shown in Fig. 3C, Balb-shCad11 cells had substan-
tially lower Rac1 levels than the parental Balb/c3T3, indicating that
cadherin-11 is required for the cell density-mediated, increase in Rac1
levels.
Cdc42 activity and protein levels mirrored Rac1 and displayed a
parallel increase with cell density (Fig. S2). The above data taken to-
gether further demonstrate that direct cadherin-11 engagement in-
duces the cell–cell adhesion-mediated increase in the levels and
activity of these two, Rho family GTPases in Balb/c3T3 and 10T½
ﬁbroblasts.
3.4. Rac1 and Cdc42 are required for the Cadherin-11 mediated, Stat3
activity increase
To examinewhether the increase in Rac1 levels we observed in con-
ﬂuent Balb/c3T3 cells is actually required for the Stat3 activity increase,
Rac1 levels were reduced through infection with a retroviral vector
carrying a Rac1-speciﬁc, shRNA insert (seeMaterials andmethods). Fol-
lowing infection and selection for puromycin resistance, Stat3-ptyr705
levels were examined at different densities as above. As shown in
Fig. 3D, there was a substantial reduction in Stat3-ptyr705 levels upon
expression of shRac1 at all densities examined. Similar results were
obtained upon Cdc42 downregulation (Fig. 3E). The residual Stat3-
ptyr705 following shRac1 expression (Fig. 3D) is most probably due to
Fig. 3. Cell density increases the activity as well as protein levels of Rac1 in Balb/c3T3 cells. Balb/c3T3 cells were grown to different densities, up to 5 days post-conﬂuence, as in-
dicated. Detergent cell lysates were probed for Stat3-ptyr705, active Rac1-GTP, total Rac1 or Hsp90 as a loading control, as indicated. Numbers at the left refer to molecular weight
markers. B. Cadherin-11 engagement is sufﬁcient to increase Rac1 protein levels. Balb/c3T3 cells were grown in plastic petris coated with 1000 μg/ml of the 11/EC12 fragment or the
E-cadherin-derived, E/EC12 fragment. 48 h later, detergent cell extracts were probed for Stat3-ptyr705, Rac1 or Hsp90 as a loading control, as indicated. Numbers at the left refer to
molecular weight markers. C. Cadherin-11 knockdown causes a dramatic decrease in Rac1 levels. Balb-shCad11 cells were grown to different densities and cell extracts probed for
cadherin-11, Rac1 or Hsp90 as a loading control. D. Rac1 is required for cadherin-11 mediated, Stat3 activation. Rac1 was downregulated in Balb/c3T3 cells through infection with a
retroviral vector (see Materials and methods). Individual clones were grown to different densities and extracts probed for Rac1, Stat3-ptyr705 or Hsp90 as a loading control, as
indicated. E. Cdc42 is required for cadherin-11 mediated, Stat3 activation. Cdc42 was downregulated in Balb/c3T3 cells through infection with a retroviral vector (see Materials
and methods). Individual clones were grown to different densities and extracts probed for Cdc42, Stat3-ptyr705 or Hsp90 as a loading control, as indicated.
1952 M. Geletu et al. / Biochimica et Biophysica Acta 1833 (2013) 1947–1959Stat3 phosphorylation mediated by Cdc42, and vice versa. The above
data taken together indicate that the Rac1 and Cdc42, Rho family
GTPases, which are dramatically activated through cell to cell adhesion,
are essential components of the pathwaywhereby cadherin-11 engage-
ment triggers the Stat3 phosphorylation and activity increase observed
at high conﬂuence.3.5. Cell density inhibits the proteasomal degradation of Rac1 in mouse
Balb/c3T3 ﬁbroblasts
We next examined the mechanism whereby Rac1 protein levels
increase with cell density. As shown in Fig. 4A, there was no increase
in Rac1 mRNA levels with cell density, measured by RT-PCR, which
1953M. Geletu et al. / Biochimica et Biophysica Acta 1833 (2013) 1947–1959points to a post-transcriptional mechanism. To examine whether this
increase in Rac1 protein levels was, in fact, due to inhibition of
proteasome-mediated degradation, we at ﬁrst made use of the MG132Fig. 4. A. Rac1 mRNA levels are not affected by cell density. Top panel: Balb/c3T3 cells were
using 18S RNA as a control (see Materials and methods). Bottom panel: Real-time RT-PCR w
each sample were determined using the 18S and 28S RNA expression levels, as an internal co
B: The proteasome inhibitor, MG132 increases total Rac1 and Stat3-ptyr705 levels. Sparsely
(lane 2), or not (lane 1) for 8 h. Detergent cell extracts were probed for total Rac1, Stat3-pty
activating enzyme increases Rac1 protein levels. ts20 (lanes 1–6) or Balb/c 3T3 (lanes 7–10)
and 9–10), as indicated. Detergent cell extracts were probed for Stat3-ptyr705, Rac1 or Hsp9
Numbers under the lanes refer to relative band intensities, with the value of lane 6 taken as
1). D: Rac1 is ubiquitinated in vivo, at low cell densities. Left panel: Extracts from Balb/c3T3
Balb/c3T3 cells were grown to 30% or 100% conﬂuence and anti-ubiquitin immunoprecipitat
cells grown to 30% conﬂuence were immunoprecipitated with normal rabbit IgG (lanes 5–6proteasome inhibitor [44]. As shown in Fig. 4B, MG132 treatment of
sparsely growing Balb/c3T3 cells caused a substantial increase in Rac1
protein levels as well as Stat3-ptyr705. At the same time, Erk1/2 levelsgrown to different densities as indicated and Rac1 mRNA levels examined by RT-PCR,
as performed as described in Materials and methods. The relative expression levels of
ntrol. B–D: Cell density inhibits the proteasomal degradation of Rac1 in Balb/c 3T3 cells.
growing Balb/c 3T3 cells were treated with 10 μM of the proteasome inhibitor, MG132
r705, pErk or Hsp90 as a loading standard, as indicated. C. Inhibition of the E1 ubiquitin
cells were grown to different densities, at 34 °C (lanes 1–3 and 7–8) or 39 °C (lanes 4–6
0 as a loading control. Numbers above the lanes refer to cell numbers/cm2 in thousands.
100%. Note the high levels of Stat3-ptyr705 at a low conﬂuence, at 39 °C (lane 4 vs lane
cells grown to 30% or 100% conﬂuence were blotted against Rac1 (arrow). Right panel:
es of detergent cell extracts blotted against Rac1 (lanes 3–4). As a control, extracts from
). Bracket points to the ubiquitinated Rac1.
1954 M. Geletu et al. / Biochimica et Biophysica Acta 1833 (2013) 1947–1959remained unchanged, indicating that, under conditions of low cell to
cell adhesion, the proteasome may be involved in Rac1 degradation
speciﬁcally.
To further demonstrate the importance of ubiquitination, we took
advantage of the ts20 cell line, derived from Balb/c3T3 ﬁbroblasts.
Due to a mutation in the gene for the ubiquitin activating enzyme
E1, which makes it susceptible to accelerated destruction, this line is
defective in protein ubiquitination at high temperatures (39 °C),
while ubiquitination is normal at 34 °C [45]. To examine the effect
of E1 inactivation upon Rac1 and Stat3-ptyr705 levels, ts20 cells
were grown to different densities at 34° or 39 °C, along with the pa-
rental Balb/c3T3, and Rac1 and Stat3-ptyr705 levels examined. The
results (Fig. 4C) revealed that in ts20 cells grown to low densities
(0.5 × 105 cells/3 cm petri) under permissive conditions (34 °C,
lane 1) or in the parental Balb/c3T3 at either temperature (lanes 7
and 9), levels of Rac1 and Stat3-ptyr705 were low. In contrast, ts20
cells grown to the same low densities at 39 °C had substantially higher
Rac1 and Stat3-ptyr705 levels (lanes 1 vs 4), pointing to the possibility
of a ubiquitination-inhibition effect. The inhibition of ubiquitination
was continuously required (see supplementary data Fig. S4). The
above data taken together demonstrate that inhibition of the ubiquitin
ligase E1 can cause a dramatic increase in both Rac1 and Stat3-
ptyr705 levels.
To further examine whether Rac1 itself might actually be a
substrate of the proteasome in sparsely growing cells, we exam-
ined whether Rac1 is modiﬁed by ubiquitin tagging in Balb/c3T3
ﬁbroblasts. To this effect, we searched for the presence of Rac1
in the pool of ubiquitinated proteins, by probing anti-ubiquitin
immunoprecipitates for Rac1 by Western blotting. In fact, a some-
what diffuse band of ubiquitin-tagged Rac1, consistent with short
chain polyubiquitination [43] was detected in immunoprecipi-
tates from cells grown to 30% conﬂuence (Fig. 4D, lane 3). This
protein complex was not present at 100% conﬂuence (lane 4),
consistent with inhibition of ubiquitination at high cell densities.
When the anti-ubiquitin antibody was replaced with normal rabbit
serum (lanes 5 and 6), or buffer alone (not shown), no Rac1 was
found in the immunoprecipitates. The above data indicate that
Rac1 itself is, in fact, a substrate of the proteasome in sparsely grow-
ing cells.3.6. NFκB and JAK are required for the cell to cell adhesion-mediated,
Stat3 activation
Early data showed that Rac1 activates NFκB [46]. To examine
whether NFκB may be required for the cell to cell adhesion-
mediated Stat3 activation, sparsely growing Balb/c3T3 cells were
trypsinized and plated at a high density (3 × 106 cells/3 cm
petri). Following attachment, cells were treated with the IKK-
inhibitor-III (BMS-345541) or the DMSO carrier alone, for 48 h.
As shown in Fig. 5A, treatment of Balb/c3T3 cells for 48 h with
this inhibitor caused a clear reduction in Stat3-ptyr705 levels
(lane 2 vs 1), while Rac1 levels were unaffected. Similar results
were obtained with caffeic acid phenethyl ester (CAPE), another
extensively employed NFκB inhibitor (not shown). These data in-
dicate that the density-mediated increase in Stat3-tyr705 phos-
phorylation requires NFκB.
The role of the JAK kinases in the conﬂuence-induced, Stat3 activa-
tion was examined next. Balb/c3T3 cells were grown to a density of
1 day after conﬂuence and treated with the pan-JAK inhibitor, JAK
inhibitor-1 [37]. As shown in Fig. 5B, there was a dramatic reduction
in Stat3-ptyr705 levels, while Rac1 protein levels remained unaffect-
ed. Similar results were obtained with the AG490 JAK inhibitor
([47]). These data suggest that the JAK kinases are required for the
cell to cell-adhesion-mediated increase in Stat3-ptyr705 levels in
mouse Balb/c3T3 ﬁbroblasts.3.7. Cell to cell adhesion triggers cytokine gene expression in mouse Balb/
c3T3 ﬁbroblasts
In order to examine the possibility that the cell density-mediated,
Stat3 activation might occur through secretion of soluble factors, a
quantitative RT-PCR array for mRNA of 86 cytokines was performed,
by comparing sparsely growing cells to cells grown as dense cultures.
The results revealed an increase in mRNA levels of a number of cyto-
kines, including the IL6 family, known to act through the common
gp130 subunit, shared by a number of Stat3 activating cytokines,
such as IL6, LIF, Ct1 and IL27 (32-fold for IL6 mRNA, see Supplemen-
tary Table S1) [48]. To examine whether these cytokines are indeed
required for the Stat3 activation observed in conﬂuent cultures, the
levels of gp130, the common subunit of the family were reduced
through expression of shRNA with a retroviral vector (see Materials
and methods). As shown in Fig. 5 (C and D), gp130 knockdown
caused a dramatic reduction in Stat3-ptyr705 levels (Fig. 5D, lanes
1–3 vs 4–6), indicating that gp130 activation is at least partly respon-
sible for the Stat3-ptyr705 increase.
3.8. Cadherin-11 engagement does not allow Erk1/2 activation by IL6
Besides Stat3, IL6 stimulation was shown to activate the Erk1/2 (Erk)
kinase by triggering its phosphorylation at a TEY sequence [49]. However,
our present data demonstrate that levels of doubly-phosphorylated,
p-Erk1/2 remained unaffected by cell density (Fig. 1B), or direct cadherin
engagement (Fig. 2), although Stat3-ptyr705 levelswere dramatically in-
creased. To solve this apparent paradox,we examined the ability of IL6 it-
self, whose synthesis is induced upon cadherin engagement and is the
trigger of Stat3 upregulation, to activate Erk as a function of cell density.
Balb/c3T3 cells were grown to 50% or 2 days postconﬂuence, serum-
starved and, following IL6 stimulation, cell extracts were probed for
p-Erk or Stat3-ptyr705. As shown in Fig. 5E, at a conﬂuence of 50%, IL6 ad-
dition caused a dramatic increase in both Stat3-ptyr705 (upper panel)
and p-Erk (lower panel) as expected, based on the published literature
[49]. As previously documented, cell density per se caused an increase
in Stat3-ptyr705 levels (Fig. 5E, upper panel lanes 1–3 vs 4–6), and IL6
caused a further activation at both densities (lanes 1 vs 3 and 4 vs 6). In-
terestingly however, in densely growing cultures IL6was unable to bring
about an increase in p-Erk levels (Fig. 5E, lower panel, lanes 4 and 5),
hinting at the possibility of a profound effect of conﬂuence on the
response of Balb/c3T3 cells to IL6 addition. To investigate whether this
might be due to cadherin function per se, the same experiment was
conducted with the Balb-shCad11 cells, which are deﬁcient in cadherin-
11. As shown in Fig. 5F, in sharp contrast to the parental Balb/c3T3
cells, IL6 could stimulate Erk in densely growing, cadherin-11 deﬁcient,
Balb-shCad11 cells (Fig. 5F, lower panel, lanes 3 vs 4), clearly indicating
that it is indeed cadherin-11 engagement that prevents Erk activation
by IL6.
3.9. Cadherin-11 plays a positive role in cell division, survival andmigration
of Balb/c3T3 ﬁbroblasts
Previous results have shown that Stat3 signalling contributes to the
induction of anti-apoptotic genes, such as Bcl-xL and mcl-1 [50,51],
while it downregulates the p53 promotor [52], thus protecting tumor
cells from apoptosis. To examine the functional consequences of the
cadherin-11 mediated, Stat3 activation, we examined the effect of
cadherin-11 knockdown in Balb/c3T3 cells. Apoptosis was examined in
Balb-shCad11 cells and the parental Balb/c3T3 by terminal deoxy-
nucleotidyl transferase dUTP nick end labeling (TUNEL) staining as be-
fore [35]. As shown in Fig. 6A, cadherin-11 deﬁcient, Balb/c3T3 cells
succumbed to apoptosis when conﬂuent (panel b), while no apoptosis
was noted in the parental Balb/c3T3, even at high densities (panel d), in-
dicating that cadherin-11 plays a positive role in cell survival signalling.
Fig. 5. A: The IKK inhibitor III inhibits the density-mediated, Rac1 activation in Balb/c3T3 cells. Balb/c3T3 cells were trypsinized and plated at a high density (106 cells/3 cm plate)
and treated with IKK inhibitor III (lane 2), or the DMSO carrier (lane 1). Cell extracts were probed for Stat3-ptyr705, Rac1 or α-tubulin as a loading standard. B: JAK inhibitor 1
reduces the density-dependent, Stat3-tyr705 phosphorylation. Balb/c3T3 cells were trypsinized and plated at a high density and treated with 0 (lane 1), or 10 (lane 2) μg/ml
JAK inhibitor 1. Cell lysates were probed for Stat3-ptyr705, Rac1 or Hsp90 as a loading standard. C–D: Gp130 knockdown causes a dramatic reduction in Stat3-ptyr705. C: Extracts
from Balb/c3T3 cells before (lane 2) or after (lane 1) gp130 knockdown were probed for gp130 or Hsp90 as a loading control. D: Extracts from Balb/c3T3 cells before (lanes 1–3) or
after (lanes 4–6) gp130 knockdown were probed for Stat3-ptyr705 or Hsp90 as a loading control. E: IL6 activates Stat3, but not Erk, at high densities in Balb/c3T3 cells. IL6 was
added at 0, 10, 50 or 100 ng/ml for 15 min to Balb/c3T3 cells grown to 50% (lanes 1–3), or 2 days postconﬂuence as indicated and cell extracts probed for Stat3-ptyr705 (upper
panel) or Hsp90 as a loading control. Note the absence of Erk activation at high densities (lower panel, lanes 4 and 5). F: IL6 activates Stat3 and Erk in the absence of
cadherin-11. Same as above, cadherin11-deﬁcient, Balb-shCad11 cells. Note the Erk activation at high densities (lower panel, lanes 3 and 4).
1955M. Geletu et al. / Biochimica et Biophysica Acta 1833 (2013) 1947–1959We next evaluated the effect of cadherin-11 downregulation upon
the rate of cell growth. As shown in Fig. 6B, cadherin-11 knockdown
cells had a doubling time of 35 h,while the doubling timeof theparental
Balb/c3T3 was 24 h, indicating that cadherin-11 plays an important,
positive role in cell proliferation.
Extensive evidence has indicated that Rac1 is required for cellmotility,
through the formation of lamellipodia at the leading edge of cells in awound healing assay [53]. Since cadherin-11 leads to Rac1 activation,
we examined the effect of cadherin-11 knockdown upon cell migration.
Balb-shCad11 cells were plated in plastic petri dishes. Two days post-
conﬂuence, a scratch-wound was introduced to the monolayer using a
plastic pipette tip, and the cells allowed to migrate into the gap. As
shown in Fig. 6C, 16 h later the parental Balb/c3T3 cells had moved to
close the wound (b), while in Balb-shCad11 cells a substantial amount
1956 M. Geletu et al. / Biochimica et Biophysica Acta 1833 (2013) 1947–1959of space was still remaining (d). Although the parental Balb/c3T3
cells grow faster than Balb-shCad11, the difference in growth rate
cannot account for the increase in rate of migration and gap closure,
within 16 h. Downregulation of Stat3 through shRNA knockdown
[54], or treatment with the CPA7 inhibitor [55] caused a similar de-
crease in cell migration of Balb/c3T3 cells (not shown), as previous-
ly reported in other systems [Arulanandam 2010][56]. Taken
together, the above ﬁndings indicate that cadherin-11 is an essen-
tial factor necessary for survival, proliferation and migration of
Balb/c3T3 cells.
4. Discussion
Unlike cells cultured in two dimensions, cells in a tissue have exten-
sive opportunities for adhesion to their neighbors. These interactions
are mediated mostly by the cadherin transmembrane protein family
members, which trigger homotypic adhesion between adjacent cells. In
addition to this structural role, cadherins profoundly inﬂuence signallingFig. 6. Cadherin-11 engagement promotes survival, proliferation and migration. A: Balb/c
TUNEL-stained for apoptosis assessment (b, d) (see Materials and methods). a, c: Same ﬁ
Balb/c3T3 or Balb-shCad11 cells were grown in petri dishes in 10% serum and cell number
experiments. C–D: Cell migration. C: Balb/c3T3 (panels a–d) or Balb-shCad11 (panels e–h
wounded. Spontaneous wound closure at each of eight marked wound sites for each line, i
sentative ﬁelds, photographed at 0 (panels a, e), 6 (panels b, f), 10 (panels c, g) or 16 h (pa
for each clone, calculated as area of wound closure at 6, 10 and 16 h, compared to t = 0. Vaevents leading to mitogenesis, survival and migration. In fact, previous
data showed that E-cadherin may often act as a tumor suppressor
molecule; it is frequently down-regulated in carcinomas [18], while
in cultured, human colon carcinoma and mammary carcinoma cell
lines, E-cadherin plays a negative role in cell proliferation [57]. In
sharp contrast, cadherin-11 and N-cadherin are aberrantly expressed
in certain cancer cells of epithelial lineage, such as breast carcinomas
with a more invasive phenotype and increased metastatic ability
[20,28,29,31], and in prostate cancer, where it promotesmetastasis spe-
ciﬁcally to the bone [30]. In the present communication we demon-
strate that homophilic interactions of cadherin-11 and N-cadherin
upregulate Stat3 and this leads to cell proliferation, survival and
migration.
These ﬁndings raise important questions: (1), is there a common
mechanism of Stat3 activation following engagement of classical,
type I and II cadherins? (2), what is the functional signiﬁcance of
the Stat3 activation, which is mediated both by cadherins that largely
inhibit metastasis, such as E-cadherin, as well as cadherins that play a3T3 or Balb-shCad11 cells were grown to densities of two days post-conﬂuence and
elds as in b, d, photographed under phase contrast illumination. B: Cell proliferation:
s obtained over several days, as indicated. Values represent averages of 3 independent
) cells were cultured to conﬂuence in 10% fetal calf serum, then the monolayer was
n two independent experiments was monitored by phase contrast microscopy. Repre-
nels d, h) are shown. Magniﬁcation: 140×. D: Histogram showing relative cell motility
lues represent mean ± SD of 4 sites per line, in each of two independent experiments.
1957M. Geletu et al. / Biochimica et Biophysica Acta 1833 (2013) 1947–1959positive role in it, such as cadherin-11 or N-cadherin? These are cru-
cial questions in the context of fundamental molecular mechanisms
of cadherin-mediated adhesion and cell and tissue survival.
4.1. Cadherin-11 engagement inhibits the proteasomal degradation of
Rac1 and Cdc42
We previously demonstrated that E-cadherin activates Rac1 and
this leads to Stat3 activation [37]. In the present communication, we
examined the effect of cadherin-11 upon Rac and Cdc42 activity,
using Balb/c3T3 cells which naturally express high amounts of this
cadherin [27]. Our results demonstrate a dramatic increase in Rac1
and Cdc42 activity with cell density. In addition, we also demonstrate
that plating Balb/c3T3 cells on surfaces coated with a cadherin-11
fragment encompassing the two outermost extracellular domains of
cadherin-11 caused a dramatic increase in Rac1 activity levels, indicating
that cadherin-11 can directly upregulate Rac1, in the absence of cell to
cell contact. These results are at variance with previous data on mouse
L cells which do not naturally express cadherins, where transfection
with cadherin-11 was found to reduce Rac1 activity [58]. It follows that
data on cadherin signalling should be interpreted in the appropriate
cellular context. Our data, using cell lines which naturally express
cadherin-11, demonstrate that Rac1 is upregulated following cadherin
homophilic ligation.
Our ﬁndings also reveal that in addition to this cadherin-induced
activation of Rac1, there is a dramatic increase in total Rac1 protein
levels with conﬂuence, without an increase in mRNA levels, leading
to a further increase in activity. Plating cells on surfaces coated with
the 11/EC12 fragment showed that this is a direct effect of cadherin
engagement. We further demonstrate that the Rac1 activation could
be due to inhibition of proteasome-mediated degradation of Rac1 upon
cadherin-11 engagement. Conversely, cadherin-11 knockdown caused
a dramatic reduction in Rac1 levels and activity. These ﬁndings are con-
sistent with previous data indicating that epithelial cell scattering
brought about by the Hepatocyte growth factor (HGF) induces the
proteasomal degradation of Rac1 [43] and demonstrate that Rac1 turn-
over mechanisms may operate in cells of mesenchymal origin as well.
A similar mechanism could hold true for Cdc42, which mirrored Rac1
activity and protein levels at all densities examined.
4.2. Cadherin-11 mediated, Rac1 upregulation activates the gp130/Stat3
axis
Wepreviously demonstrated thatmutationally activated, Rac1V12 or
Cdc42Val12 can lead to Stat3 activation ([59], reviewed in [42]). Our re-
sults now indicate that activation of Rac1/Cdc42 through cadherin-11
engagement causes a dramatic surge in mRNA levels of cytokines of
the IL6 family. The fact that downregulation of gp130, the common
subunit of the family, abolished the cell density-mediated, Stat3 activa-
tion strongly suggests that this subunit is actually required.
During developmental processes changes in the cells' cadherin
complement occur, to allow different cell types to segregate from
one another, to form tissues and organs (cadherin switching). This
is recapitulated in tumor cells and promotes metastasis [2]. The
fact that cadherin-11 knockdown did achieve a dramatic reduction
in Rac1 and Stat3-ptyr705 indicates that if cadherin switching is operat-
ing, it is not able to maintain the high Rac1 and Stat3-ptyr705 levels
observed in the parental Balb/c3T3 cells at high densities.
Our results also demonstrate that, besides cadherin-11, N-cadherin
activates Stat3 in a similar manner. Previous data demonstrated that
N-cadherin (but not E-cadherin) activates the Fibroblast Growth Factor
receptor (FGF-R), a weak Stat3 activator [60], by direct binding of their
extracellular domains. This interaction stabilizes the FGF-R by reducing
its internalization [61–63]. Similar results were later published with
cadherin-11, although the effect was less pronounced [64]. In any event,
no increase in total FGF-R or FGFR-ptyr654/653 with cell density wasnoted in Balb/c3T3 cells (not shown). The fact that gp130 knockdown
prevented Stat3 activation triggered by the engagement of three different
cadherins further underscores the importance of the IL6 family, rather
than FGF-R, in Stat3 activation. Overall, our ﬁndings obtained with differ-
ent cadherins of the type I or type II classical families, and different cell
lines derived from different tissues indicate that cadherins function to
activate Stat3, by a mechanism involving a surge in Rac1/Cdc42 levels
and activity and IL6 family upregulation, likely through upregulation of
NFκB and Jak.
4.3. Cadherin-11 engagement inhibits Erk activation by IL6
Our results demonstrate that cadherin-11 engagement triggers the
production of cytokines of the IL6 family, which were previously docu-
mented to activate the Erk pathway [49]. Surprisingly however, IL6
was found to be unable to activate Erk in Balb/c3T3 cells grown to high
densities. We further demonstrate that cadherin-11 knockdown in
Balb/c3T3 cells allowed Erk activation by IL6, which indicates that it is
cadherin-11 engagement that inhibits Erk activation by IL6.
The reasons for the Stat3 speciﬁcity are at present unclear. It is
conceivable that Erk-speciﬁc phosphatases such as Cdc25A [65] may
be activated at high densities. However, we previously showed that
other growth factors such as EGF or PDGF can activate Erk in densely
growing, mouse ﬁbroblasts [66], which argues against a blanket Erk
inhibition by cadherin engagement. The possibility that adaptors spe-
ciﬁc to IL6/gp130-mediated, Erk activation might be downregulated
following cadherin engagement is currently under investigation. It is
tempting to speculate that cadherin engagement stimulates IL6 secre-
tion in dense tissues in order to counteract apoptotic death signals,
through Stat3 activation. On the other hand, Erk would promote mainly
cell division, which is absent in contact-inhibited cells. These data are in
keeping with results from HC11 cells, which express E-cadherin [37]. In
any event, taken together, our ﬁndings demonstrate a speciﬁc Stat3 re-
sponse of cells to engagement of three different cadherins, despite the
fact that the two pathways, Erk and Stat3, have been reported to be
coordinately regulated by cytokine receptors.
4.4. Cadherin-11 engagement increases cell proliferation, survival and
motility through Stat3 activation
Previous results [29] indicated that cadherin-11 expression in the
SKBR3, breast cancer line,whichnormally expresses no knowncadherins
caused a slight increase in cell proliferation, although cadherin-11 ex-
pression alone did not transform the cells to anchorage independence.
On the other hand, cadherin-11 downregulation in PC3, prostate carcino-
ma cells had no detectable effect upon cell proliferation [30]. We now
demonstrate that cadherin-11 knockdown in normal Balb/c3T3 ﬁbro-
blasts reduced the rate of cell proliferation and led to apoptosis, especial-
ly at high densities. Since the effect of density upon Stat3 activity had not
been investigated in the lines previously examined, it is conceivable that
expression of other cadherins, or other factors activating Stat3 in the
above linesmight account for these apparent discrepancies. Our ﬁndings
are in keeping with previous data indicating that direct Stat3 inhibition
using cell permeable peptides [34] or peptidomimetics blocking the
Stat3-SH2 domain [67], pharmacological inhibitors, or genetic ablation
[35,37], in densely growing cultures induces apoptosis in mouse ﬁbro-
blasts and epithelial cells.
Cadherin-mediated, cell to cell adhesion was previously shown to
activate the PI3 kinase, a potent survival factor [68]. However, although
Rac1/Cdc42 is dramatically increased following engagement of E- or
N-cadherin or cadherin-11, no increase in Akt-p473 phosphorylation
was seen with density in cells expressing any of these three cadherins
(Fig. 1). The fact that Stat3 and not PI3k/Akt is the survival factor acti-
vated by cadherin engagement, underscores Stat3's importance in sur-
vival signalling.
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The three cadherins described so far, E-cadherin [37], N-cadherin
and cadherin-11, classical, type I and type II cadherins, in various com-
binations are present in essentially all tissues.
The fact that all activate the same Stat3 pathway, points to a central
importance of this pathway in cellular survival and may explain the
presence of at least one cadherin in all cells of the organism during em-
bryonic development and homeostasis. For tumor tissues, the demon-
stration that N-cadherin and cadherin-11 may actually activate Stat3,
despite the fact that, contrary to E-cadherin, they promote migration
and metastasis [28], may point to Stat3 as a central survival, rather
than metastasis, factor. Most importantly, inhibition of these cadherins
would induce apoptosis (through Stat3 inhibition) in metastatic cells
speciﬁcally, while normal cells expressing E-cadherin would be spared.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamcr.2013.03.014.
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